Physician profile
Thomas H Kay
NPI 1104824796
$2,840.05
in general payments reported to CMS, 2019-2025
9 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $87.15 · 2021: $1,368 · 2022: $137 · 2023: $775 · 2024: $95.89 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $638 · Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $638.11 |
| Food and Beverage | $471.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,938.52 | 2021-2023 | Psi Knee |
| Depuy Synthes Sales INC. | $482.83 | 2020-2025 | Na, Tfn-Advance |
| Stryker Corporation | $238.93 | 2019-2024 | Sharpshooter, Flexible Guide Pin (Stryker Acl Versitomic), Air |
| Orthofix Medical, INC. | $68.10 | 2021-2025 | Physio-Stim |
| Medtronic, INC. | $48.00 | 2022-2023 | Accurian |
| Ferring Pharmaceuticals INC. | $19.99 | 2019 | |
| Ethicon US, LLC | $16.41 | 2021 | |
| Sanara Medtech INC. | $14.65 | 2024 | Celleraterx |
| Heraeus Medical, LLC. | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.